LS PLASTECH’s Post

Did you know that Black women are 40% more likely to die from breast cancer compared to other racial groups? This disparity highlights the urgent need for early detection, education, and equitable access to care. Together, we can make a difference. Learn how you can support and give #Hope to those affected by #BreastCancer https://lnkd.in/gQcBVc9H #BreastCancerAwarenessMonth #HealthEquity #SWIO

Is #GenderEquity still an issue in oncology? New findings from the ESMO Women for Oncology Committee to be presented at #ESMO24 will discuss the status of gender equity in oncology. ➡️Is the growing number of female representatives in the #OncologyWorkforce also reflected in more female oncology professionals in leadership positions? ➡️What are the unique challenges for women in their professional path? ➡️What can oncology professionals do to overcome gender-related barriers in the #OncologyCommunity? Ahead of the presentation of the data during the congress, Helena Linardou, Chair of the Committee discussed all these aspects in an interview in the #ESMODailyReporter. 🔗https://ow.ly/HUqs50Tffl8

As a Breast Cancer Survivor it saddens me to read this article. Advocating for better care for Black women involves continued education and awareness. As a healthcare professionals and a patient I know this can be achieved by being informed and empathetic as well as understanding the health challenges and systemic inequities that minorities especially black women face. Some suggestions is being proactive in your healthcare. When you go to appointments prepare questions before your appointments, ensuring that all significant issues are discussed. Additionally, bringing someone along to every appointment can be beneficial. They can assist in making sure nothing is overlooked, as patients we can sometimes feel swamped by the volume of information provided. #healthcare #blackwomenshealth #healthcaredisparities #advocate

Is #GenderEquity still an issue in oncology? New findings from the ESMO Women for Oncology Committee to be presented at #ESMO24 will discuss the status of gender equity in oncology. ➡️Is the growing number of female representatives in the #OncologyWorkforce also reflected in more female oncology professionals in leadership positions? ➡️What are the unique challenges for women in their professional path? ➡️What can oncology professionals do to overcome gender-related barriers in the #OncologyCommunity? Ahead of the presentation of the data during the congress, Helena Linardou, Chair of the Committee discussed all these aspects in an interview in the #ESMODailyReporter. 🔗https://ow.ly/HUqs50Tffl8

When a woman doesn't complete Brachytherapy, she is almost 100% likely to experience cancer recurrence and death. In the US, Cervical Cancer recurrence costs the health system over $100M each year. For every 100 women who die, an additional 30 children also don’t survive childhood. At Mission-Driven Tech, we know today’s standard of care is unacceptable. We need new tools that keep women in treatment. —- ❓Did you know that only 8.8% of NIH-funded research is directed to women’s health and female founders raise 2% of all dollars invested in startups – we have to get creative. So, we’re inviting you in for an inside look at we’re building with our most recent presentation at the 2024 BrightEdge - American Cancer Society investor showcase. All through December, join our team here on LinkedIn as we share our story, vision and progress to modernize the cure for Cervical Cancer. credit to our Mission-Driven Tech team: Dr. Onyinye Balogun, MD MS, Eve McDavid, Julie Winzenried (Harn Pasco), Amanda Blake, Matthew De Remer Moved to take action? 🎁 SHARE this post with your network 🛒 SHOP our Happy Cervix™ pin: https://lnkd.in/eXYRRMBc 💲 INVEST in Mission-Driven Tech: email welcome@missiondriventech.com

Consider using these simple language swaps when talking about gynecologic cancer to help make the topic more gender inclusive! - #gynecologiccancer #genderinclusivity #healthequity #inclusivelanguage #ovariancancer #cervicalcancer #healthcommunication #sciencecommunication

Enjoyed attending the National Comprehensive Cancer Network® (NCCN®) Policy Summit discussed the importance of diversity, equity, and inclusion (DEI) as integral to the oncology workforce to improve outcomes and how to navigate backlash. National Press Club Washington DC Learn more: https://lnkd.in/eeMUpM8p #DiversityEquityInclusion #DEI #DiversityMatters #InclusionMatters

The Do it for Yourself! project found that self-collection for cervical cancer is an acceptable and feasible screening option for Aboriginal women and that self-collection can overcome some of the barriers to cervical screening facing Aboriginal women. You can read the full article and the rest of the journal here: https://hubs.li/Q02G8nS40 #Journal #Research #FirstNationsJournal

This years International Women’s Day theme is #InspireInclusion. We love that because in our #breastcancer space, DBC is fighting for inclusion. Let's recognize that screening is NOT "One Size Fits All". Let's stop excluding women at 40, women over 74, and women with #densebreasts from getting the screening they need. Let's recognize that Indigenous, Black, Asian, and Hispanic women have an earlier peak incidence of breast cancer than white women and need to have access to screening in their 40s. Let's use inclusive science to meet the needs of Canadians. Let's find breast cancer early! #InternationalWomensDay

Did you know that when breast cancer is detected early and is in the localized stage, the 5-year relative survival rate is 99%? Unfortunately, many women postpone these preventative services due to costs. That is where voluntary benefits from your organization can help play a crucial role. Read the full article from Gallagher below ⬇️ https://lnkd.in/e7zSDgxd #BreastCancerAwarenessMonth #benefits #hr #hrhelp #benefitshelp